Holly Deann Bracy, DO
Obstetrics/Gynecology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 16 years
- Touro Un Col of Osteopathic Medicine, Henderson, 2010
Offices
1 location · Capital Ob/Gyn, Inc. · 8 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bracy’s office at (916) 920-2082 to ask if they take your plan before you enroll.
State licence records
1 licence
- Texas BP10038818Physician-in-Training Permit · since 2010 · expires 2014-06-30Permit TerminatedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$4,019
Medicare paid this office $4,019 for 24 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 13 | $1,618 | $108 |
Who their Medicare patients are
24 Original Medicare patients in 2024. Average age 70 · Women 100% · Also on Medicaid 50% · Health risk score 1.05. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 67%.
The office billed $8,525, Medicare allowed $4,944 and paid $4,019; for 49 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 24 | 49 | 70 | 1.05 | $8,525 | $4,019 |
| 2022 | 12 | 17 | 69 | 1.52 | $2,988 | $1,332 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$3,699 in 2024
Medicaid paid $3,699 for 726 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Prenatal care, at-risk enhanced service; antepartum management | 353 | $3,247 |
| URINE PREGNANCY TEST | 251 | $245 |
| Return visit (30+ min) | 28 | $105 |
| Patient education, not otherwise classified, non-physician provider, individual, per session | 94 | $103 |
| 2024 | 726 | 4 | 38 | $3,699 |
| 2023 | 652 | 8 | 57 | $21,523 |
| 2022 | 1,137 | 8 | 52 | $3,546 |
| 2021 | 125 | 5 | 25 | $300 |
| 2020 | 39 | 2 | 14 | $0 |
| 2018 | 1,160 | 3 | 100 | $158,619 |
See the largest Medicaid services in earlier years
2023
| OBSTETRICAL CARE | 183 | $13,818 |
| Cesarean delivery | 37 | $5,660 |
| Prenatal care, at-risk enhanced service; antepartum management | 108 | $1,397 |
| Return visit (30+ min) | 34 | $358 |
| URINE PREGNANCY TEST | 144 | $164 |
| Patient education, not otherwise classified, non-physician provider, individual, per session | 32 | $58 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 97 | $43 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 17 | $25 |
2022
| Prenatal care, at-risk enhanced service; antepartum management | 280 | $2,521 |
| Patient education, not otherwise classified, non-physician provider, individual, per session | 220 | $461 |
| URINE PREGNANCY TEST | 178 | $170 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 15 | $145 |
| Short return visit (20+ min) | 17 | $143 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 343 | $64 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 70 | $42 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 14 | $0 |
2021
| Short return visit (20+ min) | 14 | $180 |
| Prenatal care, at-risk enhanced service; antepartum management | 21 | $73 |
| URINE PREGNANCY TEST | 51 | $41 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 25 | $6 |
| Patient education, not otherwise classified, non-physician provider, individual, per session | 14 | $0 |
2020
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 27 | $0 |
| URINE PREGNANCY TEST | 12 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 1,077 | $155,047 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 69 | $3,052 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 14 | $519 |
Drugs they prescribed that Part D paid
$5,186
Pharmacies billed $5,186 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 83) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
76 generic and fewer than 11 brand-name prescriptions · $5,186 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 12 | $925 | $77 |
| Clobetasol Propionate | 11 | $693 | $63 |
| Fluconazole | 11 | $38 | $3 |
Year by year
| 2024 | 83 | 31 | 0% (0) | None | $5,186 |
| 2023 | 63 | 20 | 0% (0) | None | $5,202 |
| 2022 | 113 | 36 | 0% (0) | None | $4,672 |
| 2021 | 50 | 20 | 0% (0) | 0% | $976 |
| 2019 | 16 | None | None | 0% | $693 |
| 2018 | 20 | 13 | None | 0% | $336 |
| 2016 | 17 | None | None | None | $316 |
| 2015 | 22 | None | None | None | $520 |
| 2013 | 34 | None | None | 68% | $2,876 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Estradiol | 13 | $1,792 | $138 |
2022: 5 drugs
| Valacyclovir | 14 | $512 | $37 |
| Estradiol | 17 | $452 | $27 |
| Clobetasol Propionate | 14 | $247 | $18 |
| Fluconazole | 12 | $82 | $7 |
| Metronidazole | 11 | $51 | $5 |
2013: 1 drug
| Mononessa | 11 | $253 | $23 |
Money from drug and device companies
$176 in 2025
| 2025 | 7 | 13 | None | $176 |
| 2024 | 6 | 13 | None | $260 |
| 2023 | 5 | 9 | None | $152 |
| 2022 | 5 | 19 | None | $248 |
| 2021 | 5 | 10 | None | $139 |
| 2020 | 3 | 3 | None | $49 |
| 2019 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Evofem Biosciences | Phexxi | $51 | 5 payments
|
| Mayne Pharma Commercial | None | $27 | 3 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $26 | 1 payment
|
| Hologic Sales and Service | Aptima | $22 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $19 | 1 payment
|
| Shield Therapeutics | Accrufer | $16 | 1 payment
|
See all 13 published payments
| Mayne Pharma Commercial | Meals · 2025-11-03 | None | $6 |
| Evofem Biosciences | Meals · 2025-09-06 | Phexxi | $2 |
| Evofem Biosciences | Meals · 2025-09-06 | Phexxi | $5 |
| Evofem Biosciences | Meals · 2025-06-06 | Phexxi | $11 |
| Boston Scientific | Meals · 2025-06-04 | Wavewriter Alpha Prime 16 | $26 |
| Mayne Pharma Commercial | Meals · 2025-06-03 | None | $8 |
| Pacira Pharmaceuticals | Meals · 2025-04-11 | Iovera | $15 |
| Evofem Biosciences | Meals · 2025-04-11 | Phexxi | $17 |
| Mayne Pharma Commercial | Meals · 2025-04-07 | None | $12 |
| Evofem Biosciences | Meals · 2025-03-14 | Phexxi | $16 |
| Shield Therapeutics | Meals · 2025-03-06 | Accrufer | $16 |
| Hologic Sales and Service | Meals · 2025-02-21 | Aptima | $22 |
| Vertex Pharmaceuticals | Meals · 2025-02-06 | Journavx | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $260
| Evofem Biosciences | None | $100 | 5 payments
|
| Organon | Nexplanon | $50 | 2 payments
|
| Sage Therapeutics | Zurzuvae | $47 | 3 payments
|
| Pfizer | Abrysvo | $32 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Mirena | $16 | 1 payment
|
| Aspira Women's Health | Ova1 | $15 | 1 payment
|
2023: $152
| Mayne Pharma Commercial | None | $56 | 4 payments
|
| Organon | Nexplanon | $37 | 2 payments
|
| Daiichi Sankyo | Injectafer | $23 | 1 payment
|
| Evofem Biosciences | Phexxi | $18 | 1 payment
|
| Sage Therapeutics | None | $18 | 1 payment
|
2022: $248
| TherapeuticsMD | Annovera | $122 | 12 payments
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $44 | 2 payments
|
| Daiichi Sankyo | Injectafer | $43 | 3 payments
|
| Pfizer | Premarin | $20 | 1 payment
|
| Organon | Nexplanon | $18 | 1 payment
|
2021: $139
| CooperSurgical | Paragard | $42 | 2 payments
|
| AbbVie | Orilissa | $38 | 2 payments
|
| Daiichi Sankyo | Injectafer | $28 | 2 payments
|
| Organon | Nexplanon | $19 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $13 | 1 payment
|
2020: $49
| Bayer HealthCare Pharmaceuticals | Kyleena | $23 | 1 payment
|
| Merck Sharp & Dohme | Nexplanon | $14 | 1 payment
|
| Mylan Pharmaceuticals | Xulane | $12 | 1 payment
|
2019: $14
| AMAG Pharmaceuticals | Makena | $14 | 1 payment
|
Professional record
- NPI
- 1205140480
- Licence
- TX BP10038818Texas BP10038818: Permit Terminated
- Trained
- Touro Un Col of Osteopathic Medicine, Henderson, 2010 · 16 years ago
- Group
- Capital Ob/Gyn, Inc.
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 701 W 5th St, Odessa, TX, 79763
- NPI first listed
- 2010-07-30
- NPI last updated
- 2020-10-22
- NPI record certified
- 2020-10-22
This is when the NPI record was last certified, not a medical board exam.